MedPath

PMS-PIMOZIDE

PMS-PIMOZIDE

Dormant
DIN Number

02239829

Drug Class

Human

Market Date

Oct 18, 2002

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02239829
AIG Number0109963001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AG02 PIMOZIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

PIMOZIDEActive
Strength: 2 MG
Monograph: PIMOZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.